Dual Shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of Liver Tumor-Initiating Cells
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The complexity of liver tumorigenesis is underscored by the recently observed anti-oncogenic effects of oncoproteins, although the mechanisms are unclear. Shp2/Ptpn11 is a proto-oncogene in hematopoietic cells and antagonizes the effect of tumor suppressor Pten in leukemogenesis. In contrast, we show here cooperative functions of Shp2 and Pten in suppressing hepatocarcinogenesis. Ablating both Shp2 and Pten in hepatocytes induced early-onset non-alcoholic steatohepatitis (NASH) and promoted genesis of liver tumor-initiating cells likely due to augmented cJun expression/activation and elevated ROS and inflammation in the hepatic microenvironment. Inhibiting cJun partially suppressed NASH-driven liver tumorigenesis without improving NASH. SHP2 and PTEN deficiencies were detected in liver cancer patients with poor prognosis. These data depict a mechanism of hepato-oncogenesis and suggest a potential therapeutic strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The functions and regulation of the PTEN tumour suppressor
Song, M. S., Salmena, L., & Pandolfi, P. P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3330 · Cited by 1,926
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764 · cited 1×
“Mice treated with DEN and fed with HFD developed HCC at 50 weeks (Park et al., 2010), but it is unclear whether these mice had NASH symptoms at young age.”
BackgroundGenetic landscape and biomarkers of hepatocellular carcinoma
Zucman-Rossi, J., Villanueva, A., Nault, J.-C., & Llovet, J. M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.061 · Cited by 1,325 · cited 2×
“Deficient expression or inactivating mutations were also detected in classical tumor suppressor genes, such as p53, RB, p21 and p27 in human liver cancers (Zucman-Rossi et al., 2015).”
BackgroundThe ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
Neel, B. G., Gu, H., & Pao, L. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00091-4 · Cited by 1,249 · cited 2×
“Shp2/Ptpn11 is the first identified oncogenic tyrosine phosphatase, with dominantly activating mutations detected in several types of leukemia (Chan and Feng, 2007), and Shp2 positively regulates Ras-Erk signaling (Lai et al., 2004; Neel et al., 2003).”
BackgroundAllosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
Chen, Y.-N. P., LaMarche, M. J., Chan, H. M., Fekkes, P., Garcia-Fortanet, J., Acker, M. G., Antonakos, B., Chen, C. H.-T., Chen, Z., Cooke, V. G., et al. (2016) · Nature · doi:10.1038/nature18621 · Cited by 925 · cited 1×
“In contrast to the anti-tumorigenic role of Shp2 described here, a recent report indicated that inhibiting Shp2 by shRNA or chemical compound selectively suppressed proliferation of cancer cells driven by receptor tyrosine kinases (Chen et al., 2016).”
BackgroundWolf, M. J., Adili, A., Piotrowitz, K., Abdullah, Z., Boege, Y., Stemmer, K., Ringelhan, M., Simonavicius, N., Egger, M., Wohlleber, D., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.003 · Cited by 678 · cited 1×
“Another NASH-HCC model was established by feeding mice with a choline-deficient HFD, which recapitulated human NASH characteristics, and 25% of the mice developed HCC after one year of feeding (Wolf et al., 2014).”
MethodER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development
Nakagawa, H., Umemura, A., Taniguchi, K., Font-Burgada, J., Dhar, D., Ogata, H., Zhong, Z., Valasek, M. A., Seki, E., Hidalgo, J., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.001 · Cited by 525 · cited 1×
“Feeding MUP-uPA transgenic mice with HFD induced signs of NASH at young age and HCC development at late stages (Nakagawa et al., 2014).”
BackgroundStiles, B., Wang, Y., Stahl, A., Bassilian, S., Lee, W. P., Kim, Y.-J., Sherwin, R., Devaskar, S., Lesche, R., Magnuson, M. A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308617100 · Cited by 436 · cited 2×
“…in Hepatocytes Trigger Early-Onset NASH PKO mice developed hepatomegaly and NAFLD at 2 months, consistent with previous reports (Horie et al., 2004; Stiles et al., 2004), but DKO animals had even more severely enlarged livers at the same age and their liver to body weight ratios increased…”
Ptpn11/Shp2 Acts as a Tumor Suppressor in Hepatocellular Carcinogenesis
Bard-Chapeau, E. A., Li, S., Ding, J., Zhang, S. S., Zhu, H. H., Princen, F., Fang, D. D., Han, T., Bailly-Maitre, B., Poli, V., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.023 · Cited by 332
Self-citation
Cited by
The functions and regulation of the PTEN tumour suppressor: new modes and prospects
Lee, Y.-R., Chen, M., & Pandolfi, P. P. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0015-0 · Cited by 917
Chen, W. S., Liang, Y., Zong, M., Liu, J. J., Kaneko, K., Hanley, K. L., Zhang, K., & Feng, G.-S. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109974 · Cited by 50
Self-citationYoon, J.-S., & Lee, C.-W. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00883-0 · Cited by 14
Liu, J. J., Xin, B., Du, L., Chen, L., Long, Y., & Feng, G. (2023) · Hepatology · doi:10.1002/hep.32555 · Cited by 11
“[12] Concurrent deletion of Shp2 and phosphatase and tensin homolog perpetuated a severe phenotype of NASH‐associated HCC,[13] and simultaneous removal of Shp2 and inhibitor of NF‐κB kinase subunit beta even induced spontaneous HCC development by causing circadian disorders.”
BackgroundSelf-citation
Metadata
- Authors
- Luo, X., Liao, R., Hanley, K. L., Zhu, H. H., Malo, K. N., Hernandez, C., Wei, X., Varki, N. M., Alderson, N., Chu, C., Li, S., Fan, J., Loomba, R., Qiu, S.-J., & Feng, G.-S.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2016-12
- Volume
- 17
- Issue
- 11
- Pages
- 2979-2993
- ISSN
- 2211-1247 (ISSN-L)
- OpenAlex
- W2566268981
- Cited by
- 56
- References
- 9
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dual Shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of Liver Tumor-Initiating Cells. https://app.cochat.ai/papers/10.1016/j.celrep.2016.11.048
- The paper
- Luo, X., Liao, R., Hanley, K. L., Zhu, H. H., Malo, K. N., Hernandez, C., Wei, X., Varki, N. M., Alderson, N., Chu, C., Li, S., Fan, J., Loomba, R., Qiu, S.-J., & Feng, G.-S. (2016). Dual Shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of Liver Tumor-Initiating Cells. Cell Reports. https://doi.org/10.1016/j.celrep.2016.11.048
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.